Scanwell launches at-home smartphone test for UTIs by Conor Hale Monday, November 4, 2019 Scanwell Health is launching a smartphone-powered home test for urinary tract infections, with an app that can also connect users to a doctor.
U.S. cancer trials still suffering from lack of diversity: report by Ben Adams Thursday, August 22, 2019 Oncology tests in the U.S. are still failing to adequately represent racial diversity, and more needs to be done to help combat this disparity.
China's Fosun pulls back from U.S. biotech scene by Nick Paul Taylor Friday, May 31, 2019 Chinese conglomerate Fosun has struck deals with Kite and other U.S. biotechs in the past but now plans to limit its activities in the country.
K2HV secures $400M to offer life science debt financing by Nick Paul Taylor Tuesday, May 21, 2019 The East Coast investor will primarily provide debt financing to enable companies to reach milestones with minimal equity dilution.
Geneva Health partners with Ochsner in remote cardiac monitoring by Conor Hale Wednesday, December 19, 2018 Ochsner Health System tapped Geneva Health Solutions to manage data collection and remote monitoring of its patients with implanted cardiac devices.
NeuroRx sees hints of efficacy in suicidal patients by Nick Paul Taylor Thursday, December 13, 2018 The small phase 2 feasibility study linked fixed-dose combination NRX-101 to improved scores on a depression rating scale.
Medtronic to pay $51M to settle claims against its acquisitions by Conor Hale Thursday, December 6, 2018 Medtronic will pay nearly $51 million to settle claims against two of its acquisitions related to unapproved device promotions and alleged kickbacks.
Implant maker ChoiceSpine acquired by Altus Capital Partners by Conor Hale Wednesday, November 21, 2018 Specialized implant manufacturer ChoiceSpine was acquired by Altus Capital Partners, marking the firm’s second medtech acquisition in two years.
Symmetry Surgical inks $97M deal for Bovie electrosurgical unit by Nick Paul Taylor Monday, July 9, 2018 The all-cash deal will give Symmetry Surgical ownership of the Bovie brand and devices used in electrosurgical procedures.
U.K. targets AI-driven 10% drop in cancer deaths by 2033 by Nick Paul Taylor Monday, May 21, 2018 The plan is to “cross reference people’s genetics, habits and medical records" along with national data to spot cancer early.